Coronavirus: Clinical Trials

5 trials for Coronavirus, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 unknown. 5 Phase 2, 2 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 25Unknown 5
Phase 12Unknown 2
Phase 31Unknown 1

Follow Coronavirus: new trials by email Literature Review of Coronavirus trials Research Report on Coronavirus

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Angiotensin-(1,7) Treatment in COVID-19: the ATCO Trial
Angiotensin 1-7, Placebos - Coronavirus, Respiratory Failure
Phase 2 / Phase 3UnknownErasme University Hospital602021-12-302021-08-02
Treatment of Patients With Mild Coronavirus-19 (COVID-19) Disease With Methotrexate Associated to LDL Like Nanoparticles (Nano-COVID19)
Methotrexate-LDE phase 1, Methotrexate-LDE phase 2, Placebo-LDE phase 2 - Coronavirus, Inflammation
Phase 1 / Phase 2UnknownUniversity of Sao Paulo General Hospital1002020-10-272021-01-14
Clinical Study of Recombinant Novel Coronavirus Vaccine
Recombinant new coronavirus vaccine (CHO cell) low-dose group, Recombinant new coronavirus vaccine (CHO cells) high-dose group, Recombinant new coronavirus vaccine (CHO cells) placebo group - Coronavirus
Phase 2UnknownAnhui Zhifei Longcom Biologic Pharmacy Co., Ltd.9002020-07-122020-12-03
COVID-19 Vaccine (ChAdOx1 nCoV-19) Trial in South African Adults With and Without HIV-infection
ChAdOx1 nCoV-19, Normal saline 0.9% - Coronavirus
Phase 1 / Phase 2UnknownUniversity of Oxford21302020-06-242020-11-27
Outcomes Mandate National Integration With Cannabis as Medicine
Cannabis, Medical, RYAH-Medtech Inhaler - Chronic Pain, Chronic Pain Syndrome
Phase 2UnknownOMNI Medical Services, LLC2000002018-12-012022-06-02

Narrower conditions

Coronavirus Infections (5)  ·  COVID-19 (2)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Amyotrophic Lateral Sclerosis (1)  ·  Anemia, Sickle Cell (1)  ·  Anxiety Disorders (1)  ·  Autistic Disorder (1)  ·  Bipolar Disorder (1)  ·  Brain Injuries, Traumatic (1)  ·  Chronic Pain (1)  ·  Chronic Traumatic Encephalopathy (1)  ·  Colitis, Ulcerative (1)  ·  Crohn Disease (1)  ·  Depression (1)  ·  Epilepsy (1)

Broader conditions

Coronaviridae Infections (5)  ·  Infections (5)  ·  Nidovirales Infections (5)  ·  RNA Virus Infections (5)  ·  Virus Diseases (5)  ·  Respiratory Tract Diseases (3)  ·  Lung Diseases (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Pneumonia (2)  ·  Pneumonia, Viral (2)  ·  Respiratory Tract Infections (2)  ·  Anemia (1)  ·  Anemia, Hemolytic (1)  ·  Anemia, Hemolytic, Congenital (1)

Interventions

ChAdOx1 nCoV-19 (1)  ·  Medical Marijuana (1)  ·  Population Groups (1)  ·  Saline Solution (1)  ·  angiotensin I (1-7) (1)

Sponsors

Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. (1)  ·  Erasme University Hospital (1)  ·  OMNI Medical Services, LLC (1)  ·  University of Oxford (1)  ·  University of Sao Paulo General Hospital (1)

Countries

Brazil (1)  ·  China (1)  ·  South Africa (1)  ·  United States (1)

Top investigators

Dr. Ryan O Lakin, MD JD (1)  ·  Filippo Annoni, MD (1)  ·  Robson AS Santos, MD,PhD (1)  ·  Shabir A Madhi, MD, PhD (1)

Results publications

PMID 32007143, PMID 32122636, PMID 32211963, PMID 32653469, PMID 33306989, PMID 33617777, PMID 33725432, PMID 33773111, PMID 34416193, PMID 36273491, PMID 36851662, PMID 37149443, PMID 8961899